Name: UMIN ID:
Unique ID issued by UMIN | UMIN000010346 |
---|---|
Receipt number | R000012082 |
Scientific Title | A phase 2 study of cyclophosphamide, lenalidomide and dexamethasone (CRD) for patients with relapsed/refractory multiple myeolma |
Date of disclosure of the study information | 2013/03/28 |
Last modified on | 2015/04/01 21:15:17 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2013/03/28 21:04:54 | ||
2 | Update | 2014/04/04 12:26:47 | Email Co-sponsor Co-sponsor |
|
3 | Update | 2015/04/01 21:15:18 | Key inclusion criteria Key inclusion criteria |